Comparison of acute kidney injury in patients prescribed vancomycin in combination with piperacillin–tazobactam or cefepime for diabetic foot infections
Sarah R Piccuirro, Anthony M Casapao, Alyssa M Claudio, Carmen Isache, Christopher A Jankowski
DOI: 10.1136/jim-2020-001594 Published 1 April 2021
Sarah R Piccuirro
1Pharmacy, UF Health Jacksonville, Jacksonville, Florida, USA
Anthony M Casapao
2College of Pharmacy, University of Florida, Jacksonville, Florida, USA
Alyssa M Claudio
1Pharmacy, UF Health Jacksonville, Jacksonville, Florida, USA
Carmen Isache
3College of Medicine, University of Florida, Jacksonville, Florida, USA
Christopher A Jankowski
1Pharmacy, UF Health Jacksonville, Jacksonville, Florida, USA
Submit a Response to This Article
No eLetters have been published for this article.
Comparison of acute kidney injury in patients prescribed vancomycin in combination with piperacillin–tazobactam or cefepime for diabetic foot infections
Sarah R Piccuirro, Anthony M Casapao, Alyssa M Claudio, Carmen Isache, Christopher A Jankowski
Journal of Investigative Medicine Apr 2021, 69 (4) 893-896; DOI: 10.1136/jim-2020-001594
Comparison of acute kidney injury in patients prescribed vancomycin in combination with piperacillin–tazobactam or cefepime for diabetic foot infections
Sarah R Piccuirro, Anthony M Casapao, Alyssa M Claudio, Carmen Isache, Christopher A Jankowski
Journal of Investigative Medicine Apr 2021, 69 (4) 893-896; DOI: 10.1136/jim-2020-001594
Comparison of acute kidney injury in patients prescribed vancomycin in combination with piperacillin–tazobactam or cefepime for diabetic foot infections
Sarah R Piccuirro, Anthony M Casapao, Alyssa M Claudio, Carmen Isache, Christopher A Jankowski
Journal of Investigative Medicine Apr 2021, 69 (4) 893-896; DOI: 10.1136/jim-2020-001594